Hemostemix Inc. Stock OTC Markets
Stocks
HMTXF
CA4236943060
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0374 USD | -10.86% |
|
-10.95% | -40.16% |
| 11:47am | Hemostemix Raises C$360,000 in the First Tranche of Private Placement of Share Units | MT |
| 06-16 | Hemostemix Inc. amended terms of the transaction | CI |
| Market Cap | 10.88M 7.67M 6.72M 6.2M 5.8M 723M 11.11M 74.49M 28.82M 358M 28.79M 28.17M 1.24B | P/E 2024 |
-4.36x | P/E 2025 | -3.12x |
|---|---|---|---|---|---|
| Enterprise Value | 13.74M 9.68M 8.49M 7.83M 7.33M 914M 14.03M 94.08M 36.4M 452M 36.37M 35.57M 1.57B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
82.24% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Hemostemix Inc.
| 1 day | -10.86% | ||
| 1 week | -10.95% | ||
| Current month | -0.80% | ||
| 1 month | -6.73% | ||
| 3 months | -25.20% | ||
| 6 months | -40.54% | ||
| Current year | -40.16% |
| 1 week | 0.04 |  | 0.04 |
| 1 month | 0.04 | | 0.04 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.12 |
| 3 years | 0.02 | | 0.28 |
| 5 years | 0.02 | | 0.33 |
| 10 years | 0.02 | | 2.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Smeenk
CEO | Chief Executive Officer | - | 2020-02-09 |
Christina Wu
DFI | Director of Finance/CFO | - | 2020-03-04 |
Fraser Henderson
CTO | Chief Tech/Sci/R&D Officer | - | 2021-10-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Smeenk
BRD | Director/Board Member | - | 2019-11-25 |
Ronnie Hershmann
BRD | Director/Board Member | 67 | 2020-02-08 |
Loran Swanberg
BRD | Director/Board Member | - | 2020-04-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.86% | -10.95% | - | - | 7.67M | |
| +0.33% | +1.37% | +64.03% | +119.11% | 55.35B | |
| +0.82% | +15.05% | +74.28% | +86.70% | 51.92B | |
| -0.48% | -0.69% | -15.62% | -16.24% | 22.76B | |
| +1.15% | +7.06% | +3.76% | +430.21% | 22.64B | |
| -0.18% | +7.20% | +28.56% | -12.48% | 17.36B | |
| -1.10% | +4.00% | +28.70% | -34.51% | 16.1B | |
| -3.35% | +8.96% | +135.18% | +294.38% | 13.96B | |
| +2.27% | +5.94% | +26.25% | +179.55% | 13.38B | |
| +1.31% | +0.53% | +27.21% | - | 12.27B | |
| Average | -1.02% | +4.62% | +41.37% | +130.84% | 25.08B | |
| Weighted average by Cap. | +0.24% | +5.29% | +47.22% | +122.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.62M -1.84M -1.62M -1.49M -1.4M -174M -2.67M -17.91M -6.93M -85.97M -6.92M -6.77M -298M | -4.71M -3.32M -2.91M -2.69M -2.51M -313M -4.81M -32.27M -12.49M -155M -12.48M -12.2M -537M |
| Net Debt | 4.23M 2.98M 2.61M 2.41M 2.26M 281M 4.32M 28.97M 11.21M 139M 11.2M 10.95M 482M | 2.86M 2.02M 1.77M 1.63M 1.53M 190M 2.92M 19.59M 7.58M 94M 7.57M 7.41M 326M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-22 | US$0.0374 | -10.86% | 16,989 |
- Stock Market
- Stocks
- HEM Stock
- HMTXF Stock
Select your edition
All financial news and data tailored to specific country editions
